Ethambutol hydrochloride contraindications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ethambutol hydrochloride}} | {{Ethambutol hydrochloride}} | ||
{{CMG}} ; | {{CMG}}; {{AE}} {{chetan}} | ||
==Contraindications== | |||
== | |||
MYAMBUTOL is contraindicated in patients who are known to be hypersensitive to this drug. It is also contraindicated in patients with known optic neuritis unless clinical judgment determines that it may be used. MYAMBUTOL is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision (e.g., young children, unconscious patients).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MYAMBUTOL (ETHAMBUTOL HYDROCHLORIDE) TABLET, FILM COATED [STI PHARMA, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b362b3cd-2c26-4af5-baa4-084217729fa5 | publisher = | date = | accessdate }}</ref> | MYAMBUTOL is contraindicated in patients who are known to be hypersensitive to this drug. It is also contraindicated in patients with known optic neuritis unless clinical judgment determines that it may be used. MYAMBUTOL is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision (e.g., young children, unconscious patients).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MYAMBUTOL (ETHAMBUTOL HYDROCHLORIDE) TABLET, FILM COATED [STI PHARMA, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b362b3cd-2c26-4af5-baa4-084217729fa5 | publisher = | date = | accessdate }}</ref> | ||
Latest revision as of 02:44, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Contraindications
MYAMBUTOL is contraindicated in patients who are known to be hypersensitive to this drug. It is also contraindicated in patients with known optic neuritis unless clinical judgment determines that it may be used. MYAMBUTOL is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision (e.g., young children, unconscious patients).[1]
References
- ↑ "MYAMBUTOL (ETHAMBUTOL HYDROCHLORIDE) TABLET, FILM COATED [STI PHARMA, LLC]". Text " accessdate " ignored (help)
Adapted from the FDA Package Insert.